Consistently, our study found that high-concentration PGD2 could inhibit the progression of DLBCL through regulating multiple biological functions, including cell proliferation, cell cycle, cell apoptosis and cell invasion. The gene discussed is PTGDS; the disease is diffuse large B-cell lymphoma.